If you want to lose weight with medication but would rather not have the conversation in a busy GP surgery or a high-street pharmacy counter, you are not doing anything unusual. "Discreet" here means two specific things: a consultation you complete privately online, and a treatment that arrives in plain, unbranded packaging. What it does not mean is skipping the clinical checks. Every genuine weight-loss medicine in the UK, including Mounjaro and Wegovy, is prescription-only and can be supplied only after a prescriber has assessed you. This guide walks through exactly how a private, discreet route works, what stays confidential and what cannot, which treatments are involved, and how to tell a properly regulated pharmacy from a risky one.
What does "discreet weight loss medication" actually mean?
The word gets used loosely, so it helps to separate the parts.
Privacy of the process means you answer a medical questionnaire from home, upload ID, and have a prescriber review your case without a face-to-face appointment or a public weigh-in. Privacy of the delivery means the parcel that arrives carries no clinic branding, no "weight loss" wording, and nothing on the outside that hints at what is inside.
Neither of those changes the fundamental point: these are potent prescription medicines. In the UK, GLP-1 treatments such as semaglutide (Wegovy) and the dual-agonist tirzepatide (Mounjaro) are Prescription-Only Medicines. A pharmacy that offers to sell them without any consultation is not being discreet, it is breaking the law, and the product may not be genuine. Discretion is about how you are treated, not about whether you are assessed.
Can you get weight loss medication without going to your GP?
Yes. A registered UK online pharmacy can prescribe and supply weight-loss medication directly, provided you meet the clinical criteria and a prescriber signs off on your case. You do not need a GP referral to start.
That said, there is an important nuance around your GP that people often misread. A private clinic will not automatically write to your GP without your consent, so your appointment record stays private if you want it to. But most prescribers will encourage you to tell your GP, because your full medical record helps everyone keep you safe, especially if you take other medicines or have other conditions. Choosing a private route is a decision about convenience and privacy; it is not a way to hide relevant history from the clinician who is prescribing to you. Being straight about your health on the questionnaire is what keeps the treatment safe.
If the "no GP appointment" part is your main draw, our guide to weight loss treatment without a GP goes into more depth on how the regulated remote route works.
Who is actually eligible?
Eligibility for licensed weight-loss medication in the UK is set by the medicine's licence, not by preference. The Medicines and Healthcare products Regulatory Agency (the Agency, the UK medicines regulator) authorises these treatments for adults with:
- a BMI of 30 or above, or
- a BMI of 27 or above with a weight-related health condition (for example high blood pressure, raised cholesterol, prediabetes, type 2 diabetes, or obstructive sleep apnoea).
This is the licensed threshold for private prescribing, and it is broader than the stricter cohorts the NHS uses to decide who it will fund. So it is entirely possible to qualify privately when you would not qualify for NHS-funded treatment. A prescriber still has to judge that the medicine is appropriate and safe for you individually; meeting the BMI line is the entry criterion, not an automatic yes.
You can see where you stand in a few minutes with a free eligibility check, and there is a fuller walk-through in our online BMI assessment guide.
How the online consultation keeps things both private and safe
An asynchronous consultation sounds clinical, but the idea is simple: you provide your information on your own time, and a prescriber reviews it on theirs. There is no video call to schedule and no waiting room.
Here is what a proper assessment asks for and why:
- Height, current weight and BMI — to confirm you meet the licensed threshold.
- Medical history and current medicines — to screen for contraindications and dangerous interactions.
- Photo ID — a legal identity check required of UK pharmacies, not an optional extra.
- Relevant conditions — for example a personal or family history of medullary thyroid cancer, or pancreatitis, which can make GLP-1 treatment unsuitable.
Crucially, a real human prescriber reviews every case. Part of that assessment is weighing the serious-but-rare risks of treatment itself: GLP-1 medicines carry a small risk of pancreatitis (inflammation of the pancreas) and gallbladder problems such as gallstones, which is one reason your history matters. If you were ever to experience a suspected side effect once on treatment, you can report it through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. If the risks outweigh the benefits, a responsible clinic declines, and that "no" is the service working as intended. The privacy is in the format; the rigour is non-negotiable. Our article on how the remote consultation works breaks the steps down further.
Which discreet treatments are available?
Two prescription options dominate the private UK market, and the right one depends on your history and preferences, not on which is trending. Here is how they compare.
| Treatment | Active ingredient | How it's taken | Trial-reported average weight loss | Notes |
|---|---|---|---|---|
| Mounjaro | Tirzepatide (GLP-1 + GIP dual agonist) | Weekly injection | ~22.5% at 72 weeks on the 15 mg dose (SURMOUNT-1) | Titrated slowly from a 2.5 mg starting dose |
| Wegovy | Semaglutide (GLP-1 agonist) | Weekly injection | ~14.9% at 68 weeks on the 2.4 mg dose (STEP-1) | Widely prescribed and well-studied in the UK |
Those percentages are averages from named clinical trials in people who also followed a reduced-calorie diet and increased their activity. They are not a promise. Real-world results vary widely from person to person, and some people lose considerably less.
A word on how the figures should be read: the 22.5% for Mounjaro comes from the highest 15 mg dose group in SURMOUNT-1, and the 14.9% for Wegovy comes from the STEP-1 trial. Different doses and different people produce different outcomes. If you want the head-to-head detail, see our Mounjaro vs Wegovy comparison.
A note on oral options you may have read about: orforglipron (Foundayo), a once-daily GLP-1 tablet from Eli Lilly, was approved in the United States in 2026 and authorised in the UK by the MHRA on 10 August 2026. We do not supply it yet, and we intend to offer it once we are able to obtain it. We cover where the tablet route stands in our oral weight-loss tablet explainer.
How the injections are dosed
Both injectable treatments start low and increase gradually, which is the single biggest lever for tolerating them well. Mounjaro begins at 2.5 mg once weekly, then increases by 2.5 mg no sooner than every four weeks, up to a maximum of 15 mg. Wegovy follows its own stepwise schedule to its 2.4 mg target dose. Rushing titration is the most common reason people feel unwell early on, so a good clinic will not let you skip steps.
You can read more on the injectable options generally in our private weight loss injections guide or the dedicated Mounjaro and Wegovy pages.
What "discreet delivery" involves — and why the cold chain matters
Discreet packaging is the part most people picture, and it is straightforward. The outer box is plain, unbranded cardboard with a standard courier label. There are no logos, no "weight loss" stickers and no medical symbols on the outside. The pharmacy label that UK law requires is on the medicine itself, kept inside. Many people ask about card statements too: a well-run pharmacy will show a discreet trading name rather than anything that spells out the contents.
The less obvious, and arguably more important, half is temperature. Semaglutide and tirzepatide are proteins, and they degrade if they get too warm. Both need to be kept between 2°C and 8°C in transit. That is why treatment is shipped in insulated packaging with medical-grade cold packs and sent on a tracked service, so it does not sit warm on a doorstep or in a depot for days.
Two practical rules follow from that:
- Be there to receive it, or use an address where someone can. A work address is fine because the packaging is plain, but the cold chain is what actually protects the medicine.
- If a parcel arrives warm or the cold packs have fully melted, do not use it. Contact the pharmacy, who can advise and replace it.
We go deeper on logistics in our Mounjaro delivery and Wegovy delivery guides.
The safety side — the part discretion should never hide
Private and discreet does not mean consequence-free, and any honest clinic will tell you about the downsides as clearly as the benefits.
The common side effects of GLP-1 medicines are gastrointestinal: nausea, constipation or diarrhoea, and reduced appetite. These are usually most noticeable when you start or step up a dose, and they tend to settle. Slow titration and smaller, less fatty meals help.
There are also serious, though rare, risks worth knowing before you start:
- Pancreatitis — severe, persistent abdominal pain that may spread to the back, sometimes with vomiting, needs urgent medical attention.
- Gallbladder problems — rapid weight loss itself raises gallstone risk.
- Dehydration — from ongoing vomiting or diarrhoea, particularly relevant if you take blood-pressure or diabetes medicines.
Some people should not take these medicines at all, including anyone with a personal or family history of medullary thyroid carcinoma, and they are not for use in pregnancy. A prescriber screens for these, which is exactly why the consultation cannot be skipped.
If you ever experience a side effect, you can and should report it through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. It is how the regulator monitors medicine safety, and your report genuinely contributes. For a fuller run-through, see our Mounjaro side effects and Wegovy side effects articles.
How to spot a genuinely regulated pharmacy
Discretion is a magnet for dodgy sellers, so the checks matter. A legitimate UK online pharmacy will:
- be registered with the General Pharmaceutical Council (GPhC), verifiable on the GPhC register;
- require a proper online consultation and identity check before supplying anything;
- prescribe only within the licensed BMI criteria;
- never offer these medicines "without a prescription" or promise guaranteed results.
If a site sells GLP-1 injections with no questions asked, walk away. It is not being discreet; it is operating illegally, and the product may be counterfeit. Our guide on choosing a regulated online pharmacy for weight loss covers the full checklist.
How it works at The Weight Clinic
The Weight Clinic is a GPhC-registered UK online pharmacy, not a lifestyle app or a subscription. The process is deliberately short and clinician-led:
- Complete a free online consultation — a medical questionnaire that takes around five to ten minutes, plus a photo ID upload.
- A UK-registered prescriber reviews your case — a real person checks your answers against the licensed criteria and your safety, and either approves, asks for more information, or explains why treatment is not suitable.
- Your medicine is dispensed and delivered discreetly — plain, unbranded, temperature-controlled packaging, with our clinical team available if you have questions about side effects or dosing.
On price, Mounjaro starts from £125 a month, and a first month of Wegovy can start from £80 (£115 standard, with £35 off your first order using code NEWME). There is no subscription and no obligation to continue.
If you would like to know whether this is an option for you, the first step is simple.
→ Check your eligibility with a free consultation.
You can also browse the full range on our treatments page.
Frequently asked questions
Is discreet weight loss medication delivery really unmarked? Yes. Treatment ships in plain, unbranded cardboard with a standard courier label and nothing on the outside referencing weight loss or the clinic. The required pharmacy label is on the medicine inside. A tracked, insulated service is used so the cold chain is maintained, which matters as much as the plain packaging.
Can I get treatment without my GP being told? A private clinic will not contact your GP without your consent, so your record stays private if you choose. However, prescribers strongly encourage you to keep your GP informed, because your full history helps them prescribe safely. Being open on the questionnaire about other conditions and medicines is essential either way.
Do I still need a consultation if I just want it delivered quietly? Yes, always. Mounjaro and Wegovy are prescription-only medicines. Any legitimate UK pharmacy must complete an online consultation, verify your identity and have a prescriber assess you before supplying. A seller offering them with no consultation is acting illegally, and the product may be unsafe.
How much does discreet weight loss medication cost in the UK? It depends on the medicine and dose. At The Weight Clinic, Mounjaro starts from £125 a month and a first month of Wegovy can start from £80 (£115 standard, with £35 off your first order via code NEWME). There is no subscription; you pay for the medicine and the clinical review. The eligibility check itself is free.
Am I eligible if I don't qualify on the NHS? Possibly. Licensed private prescribing follows the MHRA-authorised criteria: BMI 30 or above, or 27 or above with a weight-related condition. That is broader than the stricter thresholds the NHS uses to decide funding, so people who don't qualify for NHS treatment can still be eligible privately, subject to a prescriber's assessment.
What should I do if my medication arrives warm? Do not use it. Semaglutide and tirzepatide must stay between 2°C and 8°C, and heat can degrade them. If the parcel is warm or the cold packs have fully melted, contact the pharmacy, who can advise and arrange a replacement. If you experience any side effect from a medicine, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
---
This article is for general information and is not personal medical advice. Prescription weight-loss treatments are not suitable for everyone and require assessment by a qualified prescriber. Do not start, stop or change any medicine without professional advice. If you feel unwell or have urgent symptoms, contact NHS 111 or emergency services.
Frequently asked questions
Is discreet weight loss medication delivery really unmarked?
Yes. Treatment ships in plain, unbranded cardboard with a standard courier label and nothing on the outside referencing weight loss or the clinic. The required pharmacy label is on the medicine inside. A tracked, insulated service is used so the cold chain is maintained, which matters as much as the plain packaging.
Can I get treatment without my GP being told?
A private clinic will not contact your GP without your consent, so your record stays private if you choose. However, prescribers strongly encourage you to keep your GP informed, because your full history helps them prescribe safely. Being open on the questionnaire about other conditions and medicines is essential either way.
Do I still need a consultation if I just want it delivered quietly?
Yes, always. Mounjaro and Wegovy are prescription-only medicines. Any legitimate UK pharmacy must complete an online consultation, verify your identity and have a prescriber assess you before supplying. A seller offering them with no consultation is acting illegally, and the product may be unsafe.
How much does discreet weight loss medication cost in the UK?
It depends on the medicine and dose. At The Weight Clinic, Mounjaro starts from £125 a month and a first month of Wegovy can start from £80 (£115 standard, with £35 off your first order via code NEWME). There is no subscription; you pay for the medicine and the clinical review. The eligibility check itself is free.
Am I eligible if I don't qualify on the NHS?
Possibly. Licensed private prescribing follows the MHRA-authorised criteria: BMI 30 or above, or 27 or above with a weight-related condition. That is broader than the stricter thresholds the NHS uses to decide funding, so people who don't qualify for NHS treatment can still be eligible privately, subject to a prescriber's assessment.
What should I do if my medication arrives warm?
Do not use it. Semaglutide and tirzepatide must stay between 2°C and 8°C, and heat can degrade them. If the parcel is warm or the cold packs have fully melted, contact the pharmacy, who can advise and arrange a replacement. If you experience any side effect from a medicine, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
